VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
CORTES, JORGE E
One or more keywords matched the following items that are connected to
CORTES, JORGE E
Item Type
Name
Concept
Clone Cells
Academic Article
EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation.
Academic Article
Competing cell clones in myeloproliferative neoplasm.
Academic Article
Accelerated and blastic phases of chronic myelogenous leukemia.
Academic Article
del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.
Academic Article
Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays.
Academic Article
Mutant BCR-ABL clones in chronic myeloid leukemia.
Academic Article
Clonal evolution in chronic myelogenous leukemia.
Academic Article
Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
Academic Article
Philadelphia-negative acute myeloid leukemia with new chromosomal abnormalities developing after first-line imatinib treatment for chronic phase chronic myeloid leukemia.
Academic Article
T-Cell acute lymphoblastic leukemia with a "pinch" of BCR-ABL1.
Academic Article
Detection of dormant chronic myeloid leukemia clones in the bone marrow of patients in complete molecular remission.
Academic Article
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapy.
Academic Article
Tailoring tyrosine kinase inhibitor therapy to tackle specific BCR-ABL1 mutant clones.
Search Criteria
Clone Cells